Article
The effect of hematocrit and hemoglobin on the risk of ischemic heart disease: A Mendelian randomization study.
Preventive medicine - 1 Oct 2016
Zhong Y, Lin S L, Schooling C M
Abstract excerpt
Hematocrit and hemoglobin affect viscosity, and have been considered as risk factors for ischemic heart disease (IHD), although observations are inconsistent; randomized controlled trials targeting hematocrit or hemoglobin have not been definitive. To clarify their role, the risk of IHD was assessed according to genetically determined hematocrit and hemoglobin. We applied single nucleotide polymorphisms (SNPs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
